Trevena Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
135.00
-
6,250.00
3,750.00
-
5,732
Cost of Goods Sold (COGS) incl. D&A
-
239.40
-
-
490.00
-
Gross Income
-
239.40
-
-
490.00
-
SG&A Expense
22,773.50
49,710.50
56,663.30
105,787.00
68,123.00
34,158
EBIT
23,345.30
49,949.90
50,621.20
102,283.00
68,613.00
29,071
Unusual Expense
241.50
122.40
70.40
78.00
1,709.00
1,418
Non Operating Income/Expense
1.20
179.90
166.50
206.00
558.00
1,680
Interest Expense
149.80
70.70
334.40
1,738.00
2,780.00
2,231
Pretax Income
23,251.40
49,700.90
50,528.20
102,994.00
71,865.00
30,039
Consolidated Net Income
23,251.40
49,700.90
50,528.20
102,994.00
71,865.00
30,784
Net Income
23,251.40
49,700.90
50,528.20
102,994.00
71,865.00
30,784
Net Income After Extraordinaries
23,251.40
49,700.90
50,528.20
102,994.00
71,865.00
30,784
Net Income Available to Common
23,585.10
49,729.40
50,528.20
102,994.00
71,865.00
30,784
EPS (Basic)
29.71
2.02
1.15
1.97
1.21
0.42
Basic Shares Outstanding
793.80
24,655.60
43,794.30
52,398.50
59,436.60
73,558.50
EPS (Diluted)
29.71
2.02
1.15
1.97
1.21
0.42
Diluted Shares Outstanding
793.80
24,655.60
43,794.30
52,398.50
59,436.60
73,558.50
EBITDA
22,638.50
49,710.50
50,413.30
102,037.00
68,123.00
28,426
Non-Operating Interest Income
0.90
17.40
331.20
743.00
679.00
1,001
Preferred Dividends
333.70
28.50
-
-
-
-

About Trevena

View Profile
Address
955 Chesterbrook Boulevard
Chesterbrook Pennsylvania 19087
United States
Employees -
Website http://www.trevenainc.com
Updated 07/08/2019
Trevena, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of healthcare services and development of therapies. The company product pipeline consists of Olinvo, TRV250, and TRV734. Trevena was founded by Robert Joseph Lefkowitz, Scott DeWire, Howard A.